Improvement effect of fatty liver and influence of periodontitis by Amazake intake
Not Applicable
- Conditions
- Fatty liver
- Registration Number
- JPRN-UMIN000030597
- Lead Sponsor
- Saga University, Department of Organ System Interactions and Information, Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who consume Amazake for over one month 2.Complicated patients with other liver diseases such as HCV and/or HBV-infected hepatitis 3.Diabetic patients receiving insulin therapy 4.Hepatic encephalopathy, ascites, liver cancer 5.Renal failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method